Assuring Radiation Protection; Cooperative Agreement; Request for Applications: RFA-FDA-CDRH-07-004; Catalog of Federal Domestic Assistance Number: 93.103, 41510-41511 [E7-14610]

Download as PDF 41510 Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices This designation will become effective on July 22, 2007, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513– 533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. John Howard Director, National Institute for Occupational Safety and Health. [FR Doc. 07–3686 Filed 7–27–07; 8:45 am] BILLING CODE 4160–17–M DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on PROD1PC66 with NOTICES In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b (c)(6). Grant applications for the Announcement of Availability of Funds for Grants regarding Minority Research Infrastructure Support Program (M– RISP) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This 22:24 Jul 27, 2007 Jkt 211001 Dated: July 23, 2007. Carolyn M. Clancy, Director. [FR Doc. 07–3679 Filed 7–27–07; 8:45 am] BILLING CODE 4160–90–M Agency for Healthcare Research and Quality Notice of Meeting VerDate Aug<31>2005 information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Minority Research Infrastructure Support Program (M– RISP). Date: August 23, 2007 (Open on August 23 from 2 p.m to 2:15 p.m. and closed for the remainder of the meeting). Place: John M. Eisenberg Building, AHRQ Conference Center, 540 Gaither Road, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 4271554. Agenda items for this meeting are subject to change as priorities dictate. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Privacy Act of 1974; Retraction of a New System of Records Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS). ACTION: Notice of retraction of a new system of records. AGENCY: SUMMARY: The Centers for Medicare & Medicaid Services CMS inadvertently published a new system of records titled ‘‘Post Acute Care Payment Reform/ Continuity of Assessment Report and Evaluation Demonstration and Evaluation (PAC–CARE)’’ System No. 09–70–0569 in the Federal Register (FR) on Thursday, April 19, 2007 (72 FR 19711). CMS is withdrawing the notice due to comments received that a routine use disclosure provision necessary to carry out essential parts of the demonstration project was inadvertently omitted. The notice of a new system of records will be republished at a later date with the routine use included. FOR FURTHER INFORMATION CONTACT: Inquiries may be directed to: CMS Privacy Officer, Division of Privacy Compliance, Enterprise Architecture and Strategy Group, Office of PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 Information Services, CMS, Room N2– 04–27, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. He can also be reached at 410–786–5357 or by e-mail at walter.stone@cms.hhs.gov. Dated: July 18, 2007. William Saunders, Acting Deputy Director, Office of Information Services, Centers for Medicare & Medicaid Services. [FR Doc. E7–14631 Filed 7–27–07; 8:45 am] BILLING CODE 4120–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Assuring Radiation Protection; Cooperative Agreement; Request for Applications: RFA-FDA-CDRH–07–004; Catalog of Federal Domestic Assistance Number: 93.103 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. I. Funding Opportunity Description The Food and Drug Administration (FDA) is announcing its intention to receive and consider applications for the award of a cooperative agreement in fiscal year 2007 (FY07) to provide support in furtherance of FDA’s responsibilities, under section 532 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ii), to establish and carry out a comprehensive radiation control program. An estimated amount of support in FY07 will be for up to $400,000, with an additional 5 years of support, subject to the condition that in addition to FDA funds, augmenting funds are transferred to FDA from other Federal agencies to fully support this program. Funds may not be used to fund or conduct international activities or initiatives. As the lead Federal agency, FDA intends to collect funds from all other contributing Federal agencies through Interagency Agreements and fund one award for up to $400,000 in total costs (including both direct and indirect costs). After the first year, additional years of noncompetitive support are predicated upon acceptable performance during the preceding year and the availability of Federal funds. The cooperative agreement will allow FDA to continue to work with the Nuclear Regulatory Commission and its predecessor organizations, the Environmental Protection Agency and the Federal Emergency Management Agency, to provide financial support for a forum established to foster the exchange of ideas and information E:\FR\FM\30JYN1.SGM 30JYN1 Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices among the States and the Federal Government concerning radiation control. This forum has made it possible for State and Federal agencies to work together to study existing and potential radiological health problems of mutual interest and to apply their increasingly limited resources with maximum efficiency in seeking ways to address these problems, fostering coordination, and providing original views. II. Award Information The objective of this cooperative agreement is to coordinate Federal, State, and Tribal activities to achieve effective solutions to present and future radiation control problems. The recipient of this cooperative agreement award will be expected to obtain the States’ cooperation and participation on committees and working groups established to deal with individual problems. The recipient will also plan and facilitate an annual meeting, and develop and offer educational activities to demonstrate mutually beneficial techniques, procedures, and systems relevant to the mission of assuring radiation protection. The recipient will establish committees to address, evaluate, and offer solutions for a wide range of radiation health and protection issues. Examples of relevant areas of interest include, but are not limited to: (1) The application of x-rays to the healing arts, (2) the application of medical/nonmedical ionizing radiation, and (3) the control and mitigation of radiation exposure from all sources. Copyright Material: Applicants and applicants’ subgrantees and subcontractors must ensure that any projects developed in whole or in part with Federal funds will be made available to other State, territorial, local, and tribal agencies by FDA or its agents. Any copyrighted or copyrightable works shall be subject to a royalty-free, nonexclusive, and irrevocable license to the Federal Government to reproduce, publish, or otherwise use them, and to authorize others to do so for Federal Government purposes. mstockstill on PROD1PC66 with NOTICES III. Eligibility Information This cooperative agreement is available to any domestic private or public nonprofit organization (including State and local units of government) and to any domestic for-profit organization. For-profit organizations must exclude fees or profit from their requested support. Organizations described in section 501(c)(4) of the Internal Revenue Code of 1968 that engage in lobbying are not eligible to receive awards. VerDate Aug<31>2005 22:24 Jul 27, 2007 Jkt 211001 IV. Submission Information/ Requirements Applications for this program must be made electronically. To apply, applicants should visit https:// www.grants.gov1 and follow the instructions under ‘‘Apply for Grants.’’ The required application, SF424 (Research & Related) (also referred to as the ‘‘SF424 (R&R)’’), can be completed and submitted online. The package should be labeled ‘‘Response to FDA RFA number is FD07–004’’. If you experience technical difficulties with your online submission, you should contact the Grants.gov Customer Response Center. Information about submitting an application electronically can be found at https://www.grants.gov. In order to apply electronically, the applicant must have a DUNS number and register in the Central Contractor Registration (CCR) database. In addition, applicants will be required to register with the Credential Provider. Information about this is available at https://apply.grants.gov/OrcRegister,1 or by calling ORC’s help desk at 800–816– 5548. Dun and Bradstreet Number (DUNS): As of October 1, 2003, applicants are required to have a DUNS number to apply for a grant or cooperative agreement from the Federal Government. The DUNS number is a 9digit identification number that uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, call Dun and Bradstreet at 1– 866–705–5711 and identify yourself as a Federal grant applicant. Central Contractor Registration: Applicants must also register in the Central Contractor Registration (CCR) database. Applicants must have a DUNS number to begin registration in the CCR database. The CCR is a database is a government wide repository of commercial and financial information for all organizations conducting business with the Federal Government. Registration with CCR will eventually become a requirement for grant applicants and is consistent with the government wide management reform to create a citizen-centered Web presence and build e-gov infrastructures in and across agencies to establish a ‘‘single face to industry.’’ The preferred method for completing registration is on the Internet at https://www.ccr.gov.1 This Web site provides a CCR handbook with detailed information on data that 1 (FDA has verified the Web site address, but FDA is not responsible for any subsequent changes to the Web site after this document publishes in the Federal Register.) PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 41511 applicants will need prior to beginning the online registration, as well as steps to walk applicants through the registration process. Additional information concerning the application process for this cooperative agreement can be found on FDA’s Web site (https://www.fda.gov/ cdrh) and also through the Grants.gov Web site (https://www.grants.gov). Submission Date: The application receipt date August 14, 2007. No supplemental or addendum material will be accepted after the receipt date. V. Agency Contacts For additional information regarding the administrative and financial management aspects of this notice, contact Gladys M. Bohler, Food and Drug Administration (HFA–500), 5630 Fishers Lane, Rm. 2105, Rockville, MD 20857; 301–827–7168, FAX: 301–827– 7101; e-mail: gladys.melendezbohler@fda.hhs.gov. For additional information regarding the programmatic aspects of this notice, contact Sara Sutphin, Center for Devices and Radiological Health (HFZ–205), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850; 240– 276–3225, FAX: 240–276–3201; e-mail: Sara.Sutphin@fda.hhs.gov. Dated: July 23, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–14610 Filed 7–27–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed collection; Comment Request; Physicians’ Experience of Ethical Dilemmas and Resource Allocation SUMMARY: In accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13) and Office of Management and Budget (OMB) regulations at 5 CFR Part 1320 (60 FR 44978, August 29, 1995), this notice announces the intention of the Department of Bioethics, National Institutes of Health (NIHDCB) to request approval for a new information collection, Physicians’ Experience of Ethical Dilemmas and Resource Allocation. The proposed information collection was previously published in the Federal Register on May 17, 2007, on pages 27817–18 and allowed 60–days for public comment. Two public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. E:\FR\FM\30JYN1.SGM 30JYN1

Agencies

[Federal Register Volume 72, Number 145 (Monday, July 30, 2007)]
[Notices]
[Pages 41510-41511]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-14610]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Assuring Radiation Protection; Cooperative Agreement; Request for 
Applications: RFA-FDA-CDRH-07-004; Catalog of Federal Domestic 
Assistance Number: 93.103

AGENCY:  Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

I. Funding Opportunity Description

    The Food and Drug Administration (FDA) is announcing its intention 
to receive and consider applications for the award of a cooperative 
agreement in fiscal year 2007 (FY07) to provide support in furtherance 
of FDA's responsibilities, under section 532 of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 360ii), to establish and carry out a 
comprehensive radiation control program. An estimated amount of support 
in FY07 will be for up to $400,000, with an additional 5 years of 
support, subject to the condition that in addition to FDA funds, 
augmenting funds are transferred to FDA from other Federal agencies to 
fully support this program. Funds may not be used to fund or conduct 
international activities or initiatives. As the lead Federal agency, 
FDA intends to collect funds from all other contributing Federal 
agencies through Interagency Agreements and fund one award for up to 
$400,000 in total costs (including both direct and indirect costs). 
After the first year, additional years of noncompetitive support are 
predicated upon acceptable performance during the preceding year and 
the availability of Federal funds.
    The cooperative agreement will allow FDA to continue to work with 
the Nuclear Regulatory Commission and its predecessor organizations, 
the Environmental Protection Agency and the Federal Emergency 
Management Agency, to provide financial support for a forum established 
to foster the exchange of ideas and information

[[Page 41511]]

among the States and the Federal Government concerning radiation 
control. This forum has made it possible for State and Federal agencies 
to work together to study existing and potential radiological health 
problems of mutual interest and to apply their increasingly limited 
resources with maximum efficiency in seeking ways to address these 
problems, fostering coordination, and providing original views.

II. Award Information

    The objective of this cooperative agreement is to coordinate 
Federal, State, and Tribal activities to achieve effective solutions to 
present and future radiation control problems. The recipient of this 
cooperative agreement award will be expected to obtain the States' 
cooperation and participation on committees and working groups 
established to deal with individual problems. The recipient will also 
plan and facilitate an annual meeting, and develop and offer 
educational activities to demonstrate mutually beneficial techniques, 
procedures, and systems relevant to the mission of assuring radiation 
protection. The recipient will establish committees to address, 
evaluate, and offer solutions for a wide range of radiation health and 
protection issues. Examples of relevant areas of interest include, but 
are not limited to: (1) The application of x-rays to the healing arts, 
(2) the application of medical/nonmedical ionizing radiation, and (3) 
the control and mitigation of radiation exposure from all sources.
    Copyright Material: Applicants and applicants' subgrantees and 
subcontractors must ensure that any projects developed in whole or in 
part with Federal funds will be made available to other State, 
territorial, local, and tribal agencies by FDA or its agents. Any 
copyrighted or copyrightable works shall be subject to a royalty-free, 
nonexclusive, and irrevocable license to the Federal Government to 
reproduce, publish, or otherwise use them, and to authorize others to 
do so for Federal Government purposes.

III. Eligibility Information

    This cooperative agreement is available to any domestic private or 
public nonprofit organization (including State and local units of 
government) and to any domestic for-profit organization. For-profit 
organizations must exclude fees or profit from their requested support. 
Organizations described in section 501(c)(4) of the Internal Revenue 
Code of 1968 that engage in lobbying are not eligible to receive 
awards.

IV. Submission Information/Requirements

    Applications for this program must be made electronically. To 
apply, applicants should visit https://www.grants.gov\1\ and follow the 
instructions under ``Apply for Grants.'' The required application, 
SF424 (Research & Related) (also referred to as the ``SF424 (R&R)''), 
can be completed and submitted online. The package should be labeled 
``Response to FDA RFA number is FD07-004''. If you experience technical 
difficulties with your online submission, you should contact the 
Grants.gov Customer Response Center. Information about submitting an 
application electronically can be found at https://www.grants.gov. In 
order to apply electronically, the applicant must have a DUNS number 
and register in the Central Contractor Registration (CCR) database. In 
addition, applicants will be required to register with the Credential 
Provider. Information about this is available at https://
apply.grants.gov/OrcRegister,\1\ or by calling ORC's help desk at 800-
816-5548.
---------------------------------------------------------------------------

    \1\ (FDA has verified the Web site address, but FDA is not 
responsible for any subsequent changes to the Web site after this 
document publishes in the Federal Register.)
---------------------------------------------------------------------------

    Dun and Bradstreet Number (DUNS): As of October 1, 2003, applicants 
are required to have a DUNS number to apply for a grant or cooperative 
agreement from the Federal Government. The DUNS number is a 9-digit 
identification number that uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, call Dun and Bradstreet at 1-866-705-5711 and identify 
yourself as a Federal grant applicant.
    Central Contractor Registration: Applicants must also register in 
the Central Contractor Registration (CCR) database. Applicants must 
have a DUNS number to begin registration in the CCR database. The CCR 
is a database is a government wide repository of commercial and 
financial information for all organizations conducting business with 
the Federal Government. Registration with CCR will eventually become a 
requirement for grant applicants and is consistent with the government 
wide management reform to create a citizen-centered Web presence and 
build e-gov infrastructures in and across agencies to establish a 
``single face to industry.'' The preferred method for completing 
registration is on the Internet at https://www.ccr.gov.\1\ This Web site 
provides a CCR handbook with detailed information on data that 
applicants will need prior to beginning the online registration, as 
well as steps to walk applicants through the registration process.
    Additional information concerning the application process for this 
cooperative agreement can be found on FDA's Web site (https://
www.fda.gov/cdrh) and also through the Grants.gov Web site (https://
www.grants.gov).
    Submission Date: The application receipt date August 14, 2007. No 
supplemental or addendum material will be accepted after the receipt 
date.

V. Agency Contacts

    For additional information regarding the administrative and 
financial management aspects of this notice, contact Gladys M. Bohler, 
Food and Drug Administration (HFA-500), 5630 Fishers Lane, Rm. 2105, 
Rockville, MD 20857; 301-827-7168, FAX: 301-827-7101; e-mail: 
gladys.melendez-bohler@fda.hhs.gov.
    For additional information regarding the programmatic aspects of 
this notice, contact Sara Sutphin, Center for Devices and Radiological 
Health (HFZ-205), Food and Drug Administration, 1350 Piccard Dr., 
Rockville, MD 20850; 240-276-3225, FAX: 240-276-3201; e-mail: 
Sara.Sutphin@fda.hhs.gov.

    Dated: July 23, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-14610 Filed 7-27-07; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.